Optimisation of peptide-based cytotoxic T-cell determinants using

Author： Andrew I. Webb  

Publisher： Springer Publishing Company

ISSN： 0929-5666

Source： Letters in Peptide Science, Vol.10, Iss.5, 2003-01, pp. : 561-569

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Redirecting cytotoxic T lymphocyte responses with T-cell receptor transgenes

By Morse Michael   Lyerly H Kim   Clay Timothy M  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 4, 2002-04 ,pp. : 353-360

Informa Healthcare

Access to resources Recommend Favorite

Peptide-based vaccination for colorectal cancer

By Tsuruma Tetsuhiro   Hata Fumitake   Furuhata Tomohisa   Ohmura Tosei   Katsuramaki Tadashi   Yamaguchi Koji   Kimura Yasutoshi   Torigoe Toshihiko   Sato Noriyuki   Hirata Koichi  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 6, 2005-06 ,pp. : 799-807

Informa Healthcare

Access to resources Recommend Favorite

Peptide-based vaccines for cancer immunotherapy

By Brinkman Joeli A   Fausch Steven C   Weber Jeffrey S   Kast W Martin  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 2, 2004-02 ,pp. : 181-198

Informa Healthcare

Access to resources Recommend Favorite

T-Cell Antigen Receptor Assembly and Cell Surface Expression Is Not Affected by Treatment with T-Cell Antigen Receptor-Alpha Chain Transmembrane Peptide

By  

Protein and Peptide Letters, Vol. 14, Iss. 3, 2007-03 ,pp. : 299-303

Bentham Science Publishers

Access to resources Recommend Favorite

Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo

By EL Andaloussi Samir  

Nucleic Acids Research, Vol. 39, Iss. 9, 2011-05 ,pp. : 3972-3987

Oxford University Press

Access to resources Recommend Favorite